Two cases with fulminant type 1 diabetes that developed long after cessation of immune checkpoint inhibitor treatment

Various immune‐related adverse events (irAEs), including fulminant type 1 diabetes (FT1D), are known to be associated with immune checkpoint inhibitors (ICIs). We experienced two lung adenocarcinoma cases who developed fulminant type 1 diabetes long after discontinuation of ICI therapies. One, a 74‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatayama, Satoko, Kodama, Shinjiro, Kawana, Yohei, Otake, Sonoko, Sato, Daiki, Horiuchi, Takahiro, Takahashi, Kei, Kaneko, Keizo, Imai, Junta, Katagiri, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340871/
https://www.ncbi.nlm.nih.gov/pubmed/35396830
http://dx.doi.org/10.1111/jdi.13807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340871/
https://www.ncbi.nlm.nih.gov/pubmed/35396830
http://dx.doi.org/10.1111/jdi.13807

Ejemplares similares